KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Biogen (BIIB) Other Gross PP&E Adjustments (2016 - 2025)

Biogen has reported Other Gross PP&E Adjustments over the past 17 years, most recently at $3.4 billion for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $3.4 billion for Q4 2025, up 201.28% from a year ago — trailing twelve months through Dec 2025 was $3.4 billion (up 201.28% YoY), and the annual figure for FY2025 was $3.4 billion, up 201.28%.
  • Other Gross PP&E Adjustments for Q4 2025 was $3.4 billion at Biogen, up from -$460.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for BIIB hit a ceiling of $3.4 billion in Q4 2025 and a floor of -$2.5 billion in Q1 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$251.0 million (2022), compared with a mean of -$24.5 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 6653.33% in 2023 and later soared 201.28% in 2025.
  • Biogen's Other Gross PP&E Adjustments stood at $992.1 million in 2021, then dropped by 2.51% to $967.2 million in 2022, then surged by 174.4% to $2.7 billion in 2023, then tumbled by 58.03% to $1.1 billion in 2024, then soared by 201.28% to $3.4 billion in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $3.4 billion (Q4 2025), -$460.5 million (Q3 2025), and -$574.5 million (Q2 2025) per Business Quant data.